Stomach pain on GLP-1s: what is expected, what the labels warn about, and how to track it
Abdominal pain is on every GLP-1 label as a common reaction: Wegovy 20% versus 10% on placebo, Zepbound 9–10% versus 5%, Ozempic 5.7–7.3% versus 4.6%, Mounjaro 5–6% versus 4%, Saxenda 5.4% versus 3.1%. The labels also carry a warning: persistent, severe pain that may radiate to the back can be pancreatitis and needs a call. Log location, severity and timing daily so you can tell crampy meal-related pain from something new.
GLP-1 stomach pain: what it is and who reports it
GLP-1 stomach pain is the one side effect on this site with two very different meanings. The common kind is cramping, aching or a heavy fullness in the belly that comes with slowed digestion on semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound) or liraglutide (Saxenda). The rare kind is the pancreatitis warning that sits in the boxed section of every one of those labels. Tracking is for the first kind. Knowing the difference is the point of this page.
| Label | Abdominal pain (drug / placebo) |
|---|---|
| Wegovy 2.4 mg | 20% / 10% |
| Zepbound 5 / 10 / 15 mg | 9% / 9% / 10% vs 5% |
| Ozempic 0.5 / 1 mg | 7.3% / 5.7% vs 4.6% |
| Mounjaro 5 / 10 / 15 mg | 6% / 5% / 5% vs 4% |
| Saxenda | 5.4% / 3.1% (upper abdominal pain 5.1% / 2.7%) |
Notice the placebo columns. Abdominal pain is common in everyone, so the gap between drug and placebo is smaller than it is for vomiting or belching. Wegovy's 20% is the outlier and lines up with its higher target dose. Compounded Compounded Semaglutide and Compounded Tirzepatide have no label; the branded numbers are the reference.
When it tends to show up
The labels do not give abdominal pain its own timeline. Wegovy's says gastrointestinal reactions "were most frequently reported during dosage escalation." Mounjaro's and Zepbound's say most nausea, vomiting and diarrhea "occurred during dose escalation and decreased over time."
What people report is that the ordinary kind of pain follows meals and the shot calendar. It is worst in the two or three days after a shot, worst after a large meal, and often worst when constipation has built up for a few days. Many describe it as crampy and shifting rather than fixed in one place, and many say each step-up brings a week or two of more of it before things settle. Wegovy steps every four weeks and Zepbound at least four weeks apart; circle those dates.
The warning kind does not follow that pattern. It is described on the labels as persistent and severe, and it does not come and go with lunch.
What is worth logging
- Severity, 1–5, daily. A 1 is a mild ache after eating; a 5 is pain that stops you doing things. Score the worst point of the day, at the same time each evening.
- Where it is, and whether it moves. "Upper middle after dinner", "lower left, crampy" goes in the note. Location is the first thing a prescriber will ask.
- Whether it is constant or comes in waves. Crampy and shifting is the usual report; constant and deep is the one to flag.
- Days since your shot. Log the shot in the same app and the offset is automatic.
- The dose you were on. Pain at 0.5 mg and at 1 mg are separate baselines.
- Constipation, nausea and indigestion alongside. See constipation, nausea and indigestion. Stomach pain that rises with the constipation row usually has an obvious cause.
When to contact your prescriber
This section is longer than usual because abdominal pain is the one symptom every GLP-1 label tells you to watch.
- Persistent, severe abdominal pain, sometimes radiating to the back, with or without nausea or vomiting. This is the pancreatitis warning. The labels say the medicine should be discontinued if pancreatitis is suspected, so contact your prescriber promptly. It is not something to score and wait on.
- Pain with fever, or with vomiting you cannot stop. The labels tie vomiting-driven dehydration to reports of acute kidney injury. See vomiting.
- Pain in the upper right abdomen. The Wegovy, Zepbound and Saxenda labels list gallbladder problems, including cholelithiasis, as a warning. Upper right pain, especially after fatty meals, is worth a call.
- Pain that is new months into a steady dose. That is outside the escalation pattern the labels describe.
- Everyday pain that is not settling after a step-up. The labels say to consider delaying escalation if a dose is not tolerated. Your prescriber makes that call; the log makes it a short conversation.
How to do this in Peppy
- Turn stomach pain on. It is not one of the five GLP-1 defaults. Open Settings ▸ Tracking and toggle Stomach pain. Indigestion and Constipation sit in the same list.
- Score it in the daily check-in. On the Today tab tap the check-in row. Set stomach pain 1–5, put location and character in the note, add weight if you weighed in. The check-in counts toward your streak.
- Log shots with the body map. Tap the dose on the Today tab, tap the site on the silhouette, confirm the time. The dose is saved with it, so your titration ladder (Pro) becomes step-up markers on your charts.
- Read the heat-map in Progress (Pro). The stomach pain row sits with constipation and nausea on one week axis, step-ups marked. Pain that darkens with constipation and clears when it clears is a pattern. Pain that darkens alone and stays dark is a phone call. The free tier shows the chart blurred.
- Use the Calendar for the shot-day question. The week strip shows shot days; flip through check-ins and compare day two after a shot with day six.
- Export before an appointment (Pro). Settings ▸ Export produces a PDF or CSV of doses and check-ins with your notes, so "where and when" is already answered. The export guide covers what is in it.
Related: the side-effects tracking guide, the Ozempic tracker and the Mounjaro tracker pages.
Track it in Peppy
123 compounds built in, the units math done for you, body-map site rotation and reminders — private on your iPhone.
Free · iPhone · no accountFrequently asked
Is stomach pain a common side effect of GLP-1 medications?
Yes. Wegovy's label lists abdominal pain in 20% of patients versus 10% on placebo. Zepbound lists 9%, 9% and 10% at 5, 10 and 15 mg versus 5%. Ozempic lists 7.3% at 0.5 mg and 5.7% at 1 mg versus 4.6%. Mounjaro lists 6%, 5% and 5% versus 4%. Saxenda lists 5.4% versus 3.1%, plus upper abdominal pain at 5.1% versus 2.7%.
What does GLP-1 stomach pain feel like?
The labels do not describe it. Many people report cramping or a heavy ache in the upper or middle abdomen, worst after meals and in the days after a shot, often alongside nausea, bloating or constipation. That is the expected kind. A deep, constant, severe pain that spreads to the back is the kind the labels warn about.
When is stomach pain on Ozempic or Mounjaro a sign of pancreatitis?
Every GLP-1 label tells patients to watch for persistent, severe abdominal pain, sometimes radiating to the back, with or without nausea or vomiting. The labels say the medicine should be discontinued if pancreatitis is suspected, so contact your prescriber promptly. Do not wait to see if it shows a pattern in your log.
Does GLP-1 stomach pain go away?
The labels do not give a duration for abdominal pain. They say gastrointestinal reactions as a group were reported most often during dose escalation, and for Mounjaro and Zepbound that they decreased over time. Many people report the crampy, meal-related kind eases within a few weeks of each step-up.
Why does my stomach hurt after a GLP-1 injection?
The labels do not give a mechanism for abdominal pain specifically. These medicines slow gastric emptying, and many people report that food sitting longer, plus constipation and gas, is what the pain seems to come from. Logging pain alongside constipation and bloating usually shows which is driving it.
Sources
Not medical advice. Peppy is a tracking tool, not medical advice. Dose calculations are mathematical conversions only. Always follow your prescriber's instructions and verify every draw-up yourself.